Results 251 to 260 of about 1,696,934 (300)
Some of the next articles are maybe not open access.

Potential live vaccines for HIV

Vaccine, 2000
Potential live vaccines for HIV were developed using an Lpp-OmpA system to target an HIV antigen, reverse transcriptase, or an immunodominant epitope of this enzyme, to the outer membrane of an attenuated strain of Salmonella SL3261. These live vaccines were administered orally to mice, and fecal IgA and helper T cell responses were measured.
M S, Burnett   +3 more
openaire   +2 more sources

Live Attenuated Vaccine Vectors

International Journal of Technology Assessment in Health Care, 1994
AbstractSeveral different live attenuated vaccine vectors currently are under development. These vaccines are composed of living viruses or bacteria that are innocuous to the host but can replicate in host tissues and induce immune responses. The genes encoding foreign antigens can be inserted into these vectors to produce multivalent vaccines that ...
openaire   +2 more sources

Perspective on Live Varicella Vaccine

The Journal of Infectious Diseases, 2008
The attenuation of varicella-zoster virus (VZV) by Takahashi in 1974 was a remarkable achievement. It swiftly led to development of a live vaccine against chickenpox, which was initially tested in Japan. With its successful employment in immunocompromised children to prevent morbidity and mortality due to varicella, the vaccine began to be tested in ...
Anne A, Gershon, Samuel L, Katz
openaire   +2 more sources

Live Attenuated Influenza Vaccine

2014
Cold-adapted Ann Arbor based live attenuated influenza vaccine (LAIV) has been available in the USA since 2003. The vaccine is efficacious against influenza infection. Features of LAIV include: easy administration suitable for mass immunization, cross-reactivity to drifted strains for broader coverage, and establishment of herd immunity for control of ...
Hong, Jin, Kanta, Subbarao
openaire   +2 more sources

Live attenuated influenza vaccine

2008
The development of the live, attenuated influenza vaccine (LAIV), based on the cold-adapted (ca), attenuated ca A/Ann Arbor/6/60 and ca B/Ann Arbor/1/66 backbones, has spanned several decades. The vaccine contains three vaccine strains, two attenuated influenza A strains and one attenuated influenza B strain; these vaccine strains are genetic ...
Harry Greenberg, George Kemble
openaire   +1 more source

Vaccination with Live Vaccines

2022
Geraldine Blanchard-Rohner   +1 more
openaire   +1 more source

Polio Vaccines— Live or Inactivated?

JAMA: The Journal of the American Medical Association, 1966
To the Editor:— Two excellent vaccines are in current use to protect against poliomyelitis. Inactivated poliomyelitis vaccine (IPV) developed by Salk has been widely used since 1955. IPV is characterized by complete safety, imperfect immunizing power, and the need for percutaneous administration.
openaire   +2 more sources

[Live vaccines].

La Revue du praticien, 1995
Live vaccines are composed of viral or bacterial strains which are deprived of their pathogenicity but can still replicate in the organism. These vaccines can provoke a non pathogenic infection in vaccinated subjects, both inducing an antibody and a cellular immune response.
openaire   +1 more source

Effectiveness of live varicella vaccine

Expert Opinion on Biological Therapy, 2004
The disease burden of chickenpox to children has been described, and a lower force of neutralising antibody to varicella-zoster virus (VZV) than against measles, either after natural infection or after vaccination, has been reported. In the case of VZV, strong cell-mediated immunity may work efficiently to prevent the spread of the virus.
openaire   +2 more sources

Vaccination with Non-live Vaccines

2022
Geraldine Blanchard-Rohner   +1 more
openaire   +1 more source

Home - About - Disclaimer - Privacy